4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Spear Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel Tretinoin - Acne | Phase 3 | Completed | Spear Pharmaceuticals | 574 | 2013-11-01 | 2020-02-10 |
| Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo Brand Carac, Generic 0.5% 5-fluorouracil cream, Placebo cream - Actinic Keratoses | Phase 3 | Completed | Spear Pharmaceuticals | 377 | 2010-09-01 | 2014-10-20 |
| Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo Tretinoin microsphere 0.1%, Brand Retin-A Micro tretinoin microsphere gel 0.1%, placebo microsphere gel - Acne | Phase 3 | Completed | Spear Pharmaceuticals | 480 | 2009-10-01 | 2014-10-27 |
| Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and Placebo Tretinoin, placebo - Acne | Phase 3 | Completed | Spear Pharmaceuticals | 958 | 2009-10-01 | 2020-01-03 |
Acne Vulgaris (3) · Keratosis, Actinic (1)
Tretinoin (3) · Drugs, Generic (1) · Fluorouracil (1)
United States (2)
Krunal Patel, MD (1) · Melanie Appell, M.D. (1) · Susan Barker, MD (1) · William Cunningham, MD (1)